Abstract Search

ea0070aep626 | Pituitary and Neuroendocrinology | ECE2020

Surgical and survival outcomes of early peptide receptor radionuclide therapy for downstaging locally advanced or oligometastatic pancreatic neuroendocrine neoplasms

Minczeles Noémie , van Eijck CHJ , van Gils MJ , van Velthuysen MF , Nieveen van Dijkum EJM , Feelders Richard , de Herder Wouter W , Brabander* T , Hofland* Hans

Introduction: Pancreatic neuroendocrine neoplasm (pNEN) patients often present with locally advanced or metastatic disease. The objective response rate of peptide receptor radionuclide therapy (PRRT) in pNENs is 55%. Therefore, PRRT may be a possibility for patients who are not eligible for upfront curative surgery.Aims: To assess the potency of PRRT to render locally advanced or oligometastatic pNENs resectable and to evaluate the effect of surgery afte...

0 shares

Endocrine Abstracts

Surgical and survival outcomes of early peptide receptor radionuclide therapy for downstaging locally advanced or oligometastatic pancreatic neuroendocrine neoplasms

BiosciAbstracts